The Board has remanded the Veteran's claims for service connection for various eye, skin, and peripheral neuropathy conditions. The issues include secondary service connection to diabetes mellitus type II. Additional medical opinions are needed regarding whether the Veteran’s diabetes mellitus aggravates his vision and skin disorders, as well as etiology of allergic conjunctivitis and skin conditions.
The deciding factor: The Board found that the previous VA opinion was inadequate in addressing whether the Veteran's service-connected diabetes mellitus aggravated his eye and skin conditions. Additionally, there is a need for an addendum opinion regarding the etiology of the Veteran’s allergic conjunctivitis and skin disorders.
- Claimed conditions
- Refractive eye error, Bilateral cataracts disorder, Bilateral macular epiretinal membrane disorder, Allergic conjunctivitis, Seborrheic keratosis, Solar lentigines, Vitiligo
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- July 25, 2019
- Citation
- 19157594
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 19157594.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board has restored the Veteran's original 60% disability rating for seborrheic keratosis, effective November 1, 2020, as the reduction was improper due to insufficient evidence of sustained improvement in his condition.
- Granted
The Veteran's increased rating for Generalized Anxiety Disorder from August 22, 2024 is granted. For the entire appeal period, an increased rating in excess of 70 percent for Generalized Anxiety Disorder is denied. The Veteran's vitiligo remains rated at 10 percent.
- Denied
The Board denied an initial compensable rating for allergic conjunctivitis as the Veteran's condition was inactive and did not result in any residuals, including visual impairment or disfigurement.
- Partly granted
The Board granted an earlier effective date of June 2, 2022, for the award of service connection for allergic conjunctivitis and denied a rating in excess of 10 percent.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.